In vitro enzymatic assays invalidate dihydromyricetin as a potential inhibitor against enterovirus A71 3C protease: beware of fluorescence quenching artifacts
Medicinal Chemistry Research · 2026-08 · 35 (8) · 1479-1486
DOI: 10.1007/s00044-026-03592-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medicinal Chemistry Research, online erschienen am 11.07.2026. Verfasst von Jiankai Ye und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Drug Screening and Evaluation, School of Pharmacy, Wannan Medical University, Wuhu, 241002, China. Hauptthemen laut MEDLINE: Flavonols, Cysteine Endopeptidases, Enterovirus A, Human, Viral Proteins. Die Arbeit nennt 28 Literaturangaben. Gefördert von: University Enterprise Faculty Attachment Program of Anhui Province, China, Postgraduate Innovation and Entrepreneurship Program of Anhui Province, China, University Natural Science Research Project of Anhui Province, China.
Abstract (Originalsprache)
Enterovirus A71 (EV-A71) is an important pathogen that causes hand, foot, and mouth disease (HFMD) outbreaks worldwide. Although vaccines against EV-A71 have been approved in China, there are currently no efficacious antivirals for HFMD treatment. The 3C protease (3Cpro) of EV-A71, an essential enzyme involved in viral replication, represents an attractive target for antiviral development. Despite being proposed as a promising 3Cpro inhibitor through structure-based virtual screening, 3Cpro inhibition by dihydromyricetin (DHM) remains to be rigorously investigated. In this study, our quantitative enzymatic assays, including a fluorescence resonance energy transfer (FRET)-based approach and a dimeric RFP cleavage assay (DRCA), invalidated DHM as a potential 3Cpro inhibitor in vitro. Our study revealed that fluorescence quenching, a common screening artifact, should be carefully considered when natural products are identified as 3Cpro inhibitors. Candidate hit compounds from primary screening require rigorous pharmacological assessments before being reported as new findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Drug Screening and Evaluation, School of Pharmacy, Wannan Medical University, Wuhu, 241002, China.
- Department of Biopharmaceuticals, School of Pharmacy, Wannan Medical University, Wuhu, 241002, China.
- Laboratory for Drug Screening and Evaluation, School of Pharmacy, Wannan Medical University, Wuhu, 241002, China. chenyunyu@wnmc.edu.cn.
- Department of Biopharmaceuticals, School of Pharmacy, Wannan Medical University, Wuhu, 241002, China. chenyunyu@wnmc.edu.cn.
Förderung
- University Enterprise Faculty Attachment Program of Anhui Province, China
- Postgraduate Innovation and Entrepreneurship Program of Anhui Province, China
- University Natural Science Research Project of Anhui Province, China
- Outstanding Young Postgraduate Supervisor Program of Anhui Province, China
Zitieren
APA
Ye, J., Zhang, M., Zhou, J., Xu, C., & Chen, Y. (2026). In vitro enzymatic assays invalidate dihydromyricetin as a potential inhibitor against enterovirus A71 3C protease: beware of fluorescence quenching artifacts. Medicinal Chemistry Research, 35(8), 1479-1486. https://doi.org/10.1007/s00044-026-03592-9
Vancouver
Ye J, Zhang M, Zhou J, Xu C, Chen Y. In vitro enzymatic assays invalidate dihydromyricetin as a potential inhibitor against enterovirus A71 3C protease: beware of fluorescence quenching artifacts. Medicinal Chemistry Research. 2026;35(8):1479-1486. doi:10.1007/s00044-026-03592-9
BibTeX
@article{Ye2026,
author = {Ye, Jiankai and Zhang, Mingrui and Zhou, Jiahao and Xu, Chunlei and Chen, Yunyu},
title = {In vitro enzymatic assays invalidate dihydromyricetin as a potential inhibitor against enterovirus A71 3C protease: beware of fluorescence quenching artifacts},
journal = {Medicinal Chemistry Research},
year = {2026},
volume = {35},
number = {8},
pages = {1479--1486},
doi = {10.1007/s00044-026-03592-9}
}
EUVIMED